Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
KETOROLAC TROMETHAMINE vs ACETAMINOPHEN AND IBUPROFEN
Clinician-reviewed, head-to-head comparison of mechanism, dosing, pharmacokinetics, and safety profiles.
Last clinically reviewed: June 2026 · OpiCalc Medical Review Team
Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis, thereby decreasing pain and inflammation.
Acetaminophen is a centrally acting analgesic and antipyretic whose exact mechanism is not fully understood, but is thought to involve inhibition of cyclooxygenase (COX) in the brain and modulation of cannabinoid receptors. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that non-selectively inhibits COX-1 and COX-2, reducing prostaglandin synthesis.
Short-term (≤5 days) management of moderately severe acute pain requiring analgesia at the opioid level,Moderate to severe acute pain, including postsurgical pain (FDA approved for parenteral and ophthalmic use),Ophthalmic: Prevention and reduction of inflammation and pain following cataract extraction and corneal refractive surgery
Temporary relief of minor aches and pains,Reduction of fever,Off-label: Management of osteoarthritis pain, headache, dysmenorrhea
10 mg orally every 4-6 hours, not to exceed 40 mg per day; or 15-30 mg intramuscularly or intravenously every 6 hours, not to exceed 120 mg per day (maximum 60 mg for single dose).
Oral: Acetaminophen 325 mg and ibuprofen 200 mg, 1-2 tablets every 6 hours as needed, not exceeding 6 tablets/24 hours.
Terminal half-life is 5-6 hours in young adults, prolonged to 9-10 hours in elderly patients (≥65 years) and up to 12-15 hours in renal impairment (Cr Cl <30 m L/min). Context: q6h dosing interval recommended; accumulation risk in elderly/renal impairment.
Acetaminophen: 2-3 hours (normal hepatic function). Ibuprofen: 2-4 hours (immediate-release); prolonged in overdose or hepatic impairment.
Contraindicated in patients with advanced renal impairment (Cr Cl <30 m L/min). For Cr Cl 30-60 m L/min: reduce dose by 50% and limit to 60 mg/day IM/IV or 20 mg/day oral. No adjustment for mild impairment.
GFR 30-59: Caution, use lowest effective dose; GFR <30: Contraindicated due to ibuprofen component.
Cardiovascular risk: NSAIDs increase the risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. Risk may increase with duration of use and in patients with cardiovascular risk factors. Contraindicated for treatment of perioperative pain in coronary artery bypass graft (CABG) surgery. Gastrointestinal risk: NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time without warning symptoms. Elderly patients and those with a prior history of peptic ulcer disease or GI bleeding are at greater risk.
Pregnancy Category C in first and second trimesters, Category D in third trimester and near term. Avoid in third trimester due to risk of premature closure of ductus arteriosus and oligohydramnios. First trimester: limited human data, animal studies show adverse effects. Second trimester: use only if clearly needed; may cause fetal renal impairment.
First trimester: Acetaminophen is considered low risk; ibuprofen is associated with increased risk of miscarriage and cardiac defects. Second trimester: Acetaminophen is safe; ibuprofen is relatively safe but may cause oligohydramnios. Third trimester: Acetaminophen is safe; ibuprofen is contraindicated due to risk of premature closure of ductus arteriosus, oligohydramnios, and neonatal renal impairment.
Ketorolac is a potent NSAID for short-term management of moderate to severe acute pain, not to exceed 5 days due to increased risk of GI bleeding, renal impairment, and cardiovascular events. Contraindicated in patients with active peptic ulcer disease, recent GI bleeding, advanced renal impairment, or at risk for bleeding (e.g., concurrent anticoagulants). Administer with food to reduce GI irritation; avoid use in patients with aspirin-sensitive asthma. Monitor renal function, liver enzymes, and signs of bleeding. Intramuscular injection should be given deeply and slowly; IV bolus over at least 15 seconds. Use lowest effective dose for shortest duration; not for minor or chronic pain. Not recommended for pediatric patients or during labor/delivery.
Combination product for acute pain; fixed-dose may exceed recommended daily acetaminophen limit if other acetaminophen-containing products are used. Onset of ibuprofen is 30-60 min, acetaminophen 15-30 min; duration 4-6 hours. Caution in renal impairment (ibuprofen) and hepatic impairment (acetaminophen). Avoid in third trimester of pregnancy.
No interactions on record
No interactions on record
Common clinical questions about KETOROLAC TROMETHAMINE vs ACETAMINOPHEN AND IBUPROFEN, answered by our medical review team.
KETOROLAC TROMETHAMINE is a NSAID that works by Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis, thereby decreasing pain and inflammation.. ACETAMINOPHEN AND IBUPROFEN is a NSAID that works by Acetaminophen is a centrally acting analgesic and antipyretic whose exact mechanism is not fully understood, but is thought to involve inhibition of cyclooxygenase (COX) in the brain and modulation of cannabinoid receptors. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that non-selectively inhibits COX-1 and COX-2, reducing prostaglandin synthesis.. They differ in pharmacokinetic profiles, FDA-approved indications, and side effect profiles.
Potency comparisons between KETOROLAC TROMETHAMINE and ACETAMINOPHEN AND IBUPROFEN depend on the specific clinical indication. These are both NSAID agents and are not directly interchangeable by dose. A physician or clinical pharmacist should guide any therapeutic switching decisions.
The standard adult dose of KETOROLAC TROMETHAMINE is: 10 mg orally every 4-6 hours, not to exceed 40 mg per day; or 15-30 mg intramuscularly or intravenously every 6 hours, not to exceed 120 mg per day (maximum 60 mg for single dose).. The standard adult dose of ACETAMINOPHEN AND IBUPROFEN is: Oral: Acetaminophen 325 mg and ibuprofen 200 mg, 1-2 tablets every 6 hours as needed, not exceeding 6 tablets/24 hours.. Dosing should always be individualized based on indication, renal and hepatic function, age, and other patient factors.
No direct drug-drug interaction has been formally documented between KETOROLAC TROMETHAMINE and ACETAMINOPHEN AND IBUPROFEN in current clinical databases. However, individual patient risk factors including other medications, organ function, and comorbidities should always be evaluated by a qualified healthcare provider.
The maternal-fetal safety profiles differ. KETOROLAC TROMETHAMINE is classified as Category D/X. Pregnancy Category C in first and second trimesters, Category D in third trimester and near term. Avoid in third trimester due to risk of premature closure of ductus arteriosus and. ACETAMINOPHEN AND IBUPROFEN is classified as Category D/X. First trimester: Acetaminophen is considered low risk; ibuprofen is associated with increased risk of miscarriage and cardiac defects. Second trimester: Acetaminophen is safe; ibup. Always consult a maternal-fetal medicine specialist before taking either drug during pregnancy or lactation.
Hepatic metabolism via conjugation (glucuronidation) and hydroxylation (involves CYP450 enzymes, primarily CYP2C9). Renal excretion of metabolites and unchanged drug (approximately 90% as glucuronide conjugates).
Acetaminophen is primarily metabolized via glucuronidation and sulfation; a minor pathway via CYP2E1 produces a toxic metabolite, NAPQI. Ibuprofen is metabolized primarily by CYP2C9 and to a lesser extent by CYP2C8.
Primarily renal excretion: ~92% of dose excreted in urine as parent drug (60%) and metabolites (p-hydroxyketorolac, conjugated forms). Fecal excretion accounts for ~6%. Biliary excretion is minimal.
Acetaminophen: renal excretion of metabolites (glucuronide 55%, sulfate 30%, cysteine/mercapturate <10%); <5% unchanged. Ibuprofen: renal excretion of metabolites (conjugates) 90%; <10% unchanged; minor biliary/fecal.
99% bound to plasma albumin. High binding limits distribution and may be affected by hypoalbuminemia.
Acetaminophen: 10-25% (albumin). Ibuprofen: >99% (albumin).
0.15-0.3 L/kg (apparent Vd). Relatively low, indicating limited extravascular distribution; clinically correlates with low tissue penetration.
Acetaminophen: 0.9 L/kg; Ibuprofen: 0.15 L/kg (highly protein-bound, low Vd).
Oral: 80-100%. Intramuscular: 100%. Ophthalmic: minimal systemic absorption (<0.5% of ocular dose).
Acetaminophen: 75-85% oral. Ibuprofen: 80-100% oral.
No specific dosing adjustment recommended for mild to moderate hepatic impairment (Child-Pugh A or B). Contraindicated in severe hepatic disease (Child-Pugh C).
Child-Pugh A: No adjustment; Child-Pugh B: Caution, reduce acetaminophen dose; Child-Pugh C: Contraindicated.
For patients <16 years: 0.5 mg/kg (maximum 15 mg) single dose IM/IV. Not recommended for repeated dosing or oral use in pediatric patients.
Weight-based: 10-15 mg/kg acetaminophen + 5-10 mg/kg ibuprofen per dose, every 6-8 hours, max 4 doses/day.
For patients ≥65 years: reduce dose by 50% (maximum 60 mg/day IM/IV or 20 mg/day oral). Limit duration to 5 days total therapy.
Use lowest effective dose; monitor renal function due to ibuprofen; avoid durations >10 days.
Acetaminophen may cause severe liver injury, including acute liver failure, at doses exceeding 4,000 mg/day. Ibuprofen: NSAIDs increase risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. Risk increases with duration of use and in patients with cardiovascular risk factors. NSAIDs also increase risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of stomach or intestines.
Acetaminophen: Hepatotoxicity risk with excessive doses, use with caution in hepatic impairment, avoid with alcohol use >3 drinks/day. Ibuprofen: Cardiovascular risk, gastrointestinal bleeding, renal toxicity, hypertension, fluid retention, avoid late pregnancy.
Acetaminophen: Severe hepatic impairment, allergy to acetaminophen. Ibuprofen: Hypersensitivity to ibuprofen or other NSAIDs, history of asthma/urticaria after NSAIDs, perioperative pain in CABG surgery, severe heart failure, active GI bleeding, late pregnancy.
Take with food or milk to minimize gastrointestinal irritation. Avoid concomitant use of alcohol as it increases risk of GI bleeding. No specific food interactions; however, high-fat meals may delay absorption but not affect overall efficacy.
Avoid alcohol; take with food or milk to minimize GI irritation. No specific food restrictions.
Excreted into breast milk; M/P ratio approximately 0.037. Avoid breastfeeding due to potential adverse effects in nursing infants (e.g., gastrointestinal bleeding, renal impairment).
Acetaminophen: low levels in breast milk, M/P ratio ~0.9; considered compatible with breastfeeding. Ibuprofen: minimal excretion, M/P ratio ~0.01; considered compatible. Combination: low risk with recommended doses.
No standard dose adjustment recommended; avoid use in third trimester. In first and second trimesters, use lowest effective dose for shortest duration. Pharmacokinetic changes in pregnancy may increase clearance, but no specific dosing adjustments are established.
No standard adjustment for acetaminophen; ibuprofen dosing unchanged in pregnancy but avoid in third trimester; consider increased clearance of acetaminophen in pregnancy but no dose adjustment recommended.
Take this medication exactly as prescribed, usually every 6 to 8 hours, for the shortest time needed (no more than 5 days).,Take with food or a full glass of milk to reduce stomach upset.,Avoid alcohol, aspirin, or other NSAIDs (like ibuprofen, naproxen) while taking this drug.,Stop taking and contact your doctor immediately if you experience signs of bleeding (black tarry stools, vomit that looks like coffee grounds, unusual bruising), chest pain, shortness of breath, weakness on one side of the body, or slurred speech.,Do not use this medicine if you have a history of stomach ulcers, bleeding problems, severe kidney disease, or if you are breastfeeding or in late pregnancy.,Tell your doctor about all medications you take, including blood thinners, steroids, diuretics, and lithium.
Do not exceed 10 tablets (500 mg acetaminophen/200 mg ibuprofen) per day.,Do not take with other products containing acetaminophen or NSAIDs.,Take with food or milk to reduce stomach upset.,Avoid alcohol while taking this medication.,Seek medical help if pain persists >10 days or fever >3 days.,Store at room temperature, away from moisture.